Has Rachid Idrissi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,486 in general payments to Rachid Idrissi, MD across 142 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rachid Idrissi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rachid Idrissi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rachid Idrissi, MD

Pain Medicine · Benson, NCNPI 1174696363

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Nevro Corp. at 28.4% of the total. Reporting peaked in 2023 at $2,462 and has fallen 80.9% since, to $471 in 2025.

$7,486in general payments, 2019–2025

Across 142 payments — averaging $52.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nevro Corp.$2K
Lumenis BE Inc$2K
Medtronic$1K
Biotronik NRO, Inc.$516
Abbott$314
Globus Medical$292
plus $1K from 17 others

What the payments were for

Food & beverage$7,486100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nevro Corp.	40	$2,128
Lumenis BE Inc	1	$1,810
Medtronic(2 entities)	20	$1,322
Biotronik NRO, Inc.	6	$516
Abbott	19	$314
Globus Medical	7	$292
Si-bone, Inc.	7	$187
MDD US Operations, LLC	8	$150
Boston Scientific	4	$135
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	7	$123
Medline Industries LP	2	$92
Amgen	4	$84
SPR Therapeutics, Inc	1	$77
Arbor Pharmaceuticals, Inc.	3	$46
Biodelivery Sciences International, Inc.	3	$37
Scilex Pharmaceuticals Inc.	2	$35
Lilly USA, LLC	2	$30
Vertos Medical, Inc.	1	$25
Valinor Pharma, LLC	1	$24
Daiichi Sankyo Inc.	1	$17
Mallinckrodt Hospital Products Inc.	1	$17
AstraZeneca	1	$15
Sentynl Therapeutics, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

M22$1,810
INTELLIS$496
Senza$418
Omnia$233
INTELLIS ADAPTIVESTIM$215
BIOTRONIK$145
ADAPTIVESTIM$137
Prospera$132
Senza Spinal Cord Stimulation System$111

How this compares

$7,486 in reported general payments places this provider in the 65th percentile of 182 pain medicine providers in North Carolina.

See all pain medicine providers in North Carolina →

Medicare billing

Part B allowed, 2024

$194,824

Medicare patients

303

Services billed

2,290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	26	$1,424
Oxycodone Hcl	27	$1,050
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	28	$696
Gabapentin	38	$432
Ibuprofen	18	$143
Baclofen	11	$105
Cyclobenzaprine Hcl	14	$45
Diazepam	11	$16

Paid to pharmacies, not to this prescriber.

Other pain medicine in Benson

James NorthWinston Salem$721K
Leonardo KapuralWinston Salem$523K
Christopher GilmoreWinston Salem$457K
Richard RauckWinston Salem$431K
Courtney AumanJacksonville$186K
Jacob WangCharlotte$162K
Aashish KumarCharlotte$160K
Javid BakshAsheville$116K
David ZubLeland$97K
James DeeringCharlotte$93K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →